HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
2021 sales of KRW 101.6 billion for a 15% increase from 2020 2021 operating profit of KRW 10.1 billion grew by 70% from 2020 Increasing milestone payments and revenues from R&D activities are reinvested into new R&D programs SEOUL, South Korea, Jan. 20, 2022 /PRNewswire/ --...
Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas
AUSTIN, Texas, Jan. 20, 2022 /PRNewswire/ --VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the results of two large scale clinical studies, which show that the company's Nu.Q® assays, when used in conjunction with the Fecal Immunochemical Test (FIT), can detect colorectal cancer and all high-risk advanced adenomas in symptomatic patients, and thereby reduce...
Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing
CSafe Global makes strategic addition to its senior leadership team bringing Bridget Johnson on board as the SVP of Marketing DAYTON, Ohio, Jan. 20, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced today that Bridget Johnson has joined the company's senior leadership team as Senior Vice President of...
I’mbesideyou Inc. SELECTED AS FINALIST FOR 2022 SXSW PITCH
I'mbesideyou Inc. to showcase system for visualizing Psychological Safety and Mental Health status in the Future of Work category TOKYO, Jan. 20, 2022 /PRNewswire/ -- I'mbesideyou Inc., the startup founded for healing the pain of COVID-19 was selected as a finalist in the Future of Work category for the 14th annual SXSW Pitch® (formerly SXSW Accelerator). The SXSW Pitch is the...
Victor Papamoniodis Joins Medison Pharma as VP International Markets
ZUG, Switzerland, Jan. 20, 2022 /PRNewswire/ -- Medison, a global pharma company focused on providing access to highly innovative therapies to patients in international markets ("Medison"), is proud to announce the joining of Victor Papamoniodis in the newly created position of VP International Markets. Victor will be based in Zug, Switzerland, Medison's international headquarters. ...
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment
MELBOURNE, Australia, Jan. 20, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, today announced that the first patient with metastatic castration-resistant prostate cancer (mCRPC) has been successfully dosed in a Phase I clinical trial of HP518, a highly selective and orally bioavailable...
Senhwa’s Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer
TAIPEI and SAN DIEGO, Jan. 20, 2022 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Silmitasertib, a highly selective inhibitor of casein...
Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted...
Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. MOSCOW, Jan. 20, 2022 /PRNewswire/ -- A unique comparative study conducted at the Italian Spallanzani Institute,...
Successful Groundbreaking Ceremony for GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China
ZHENJIANG, China, Jan. 20, 2022 /PRNewswire/ -- GenScript ProBio, a global antibody and gene therapy contract development and manufacturing organization (CDMO), has announced 2022 manufacturing expansion plans to meet the increasing demand for commercial cGMP plasmid and viral vector manufacturing to service its cell and gene therapy global clients. On January 19, 2022, GenScript ProBio broke ground for the construction...
Successful Completion of First Patient Implantation of MINI WELL® and MINI WELL TORIC® Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI
CATANIA, Italy, Jan. 20, 2022 /PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered in Italy, is pleased to divulge the successful completion of the first patient implantation of MINI WELL® and MINI WELL TORIC® IOLs in China, announced via Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI. MINI WELL®...
